ChainGen Bio

ChainGen Bio is developing a comprehensive toolbox that includes proprietary TfR binding modules and innovative conjugation technologies, enabling the transport of various therapeutic cargoes across the blood-brain barrier and to muscle tissues. This versatile toolbox is being expanded and applied to multiple targets and modalities, resulting in the creation of a BBB-crossing bispecific Aβ-TfR antibody and MSTN/ACVR2 targeting antibody-oligo conjugates, each holding best-in-class potential.